Primers and RACE sequences for BALR-6. Table S2. Antibodies used for bone marrow transplant flow cytometry analysis, and population gating schematics. Tables S3. Antibodies used for CD34 enrichment of human bone marrow flow cytometry analysis, and population gating schematics. (PDF 125 kb
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Table S1. Outcomes of patients with AITL who underwent allogeneic HCT. Table S2. Variables tested in...
Figure S5. Gating strategy for in vivo bone marrow samples. Bone marrows were harvested from KG1a-en...
Table S1. Patient’s characteristic of gene expression cohort. Table S2. Patient’s characteristic ex ...
BALR-6 locus encodes numerous alternative splice forms. Figure S2. Knockdown and overexpression of f...
Immunophenotypes of the leukemic cells remain stable for serial transplantations. (A) Representative...
Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...
List of antibodies used for the identification, characterization and isolation of bone marrow mesenc...
Figure S1. Flow cytometry analysis of CD45+CD33+ leukemia cells in peripheral blood of 14 and 7Â day...
Supplemental Information. Table S1. The source of primary antibodies used in this study. Table S2. T...
Table S1. Fluorochrome-coupled antibodies and/or chemical dyes for flow cytometry. Table S2. AML-der...
Figure S1. Showing generation and differentiation of hBMSC-TERT-Luc cell lines, Table S1 presenting ...
Figure S1. Expression of CD19/CD20, CD79A/B and RAG1/RAG2 in blood cancer cell lines. X axis: 164 bl...
Treatment resulted in a differential expression of 941 genes ( pâ <â0.05). (PDF 256 kb
Table S1-S2. Clinicopathological characteristics of CRC Patients named dataset (I) investigated by t...
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Table S1. Outcomes of patients with AITL who underwent allogeneic HCT. Table S2. Variables tested in...
Figure S5. Gating strategy for in vivo bone marrow samples. Bone marrows were harvested from KG1a-en...
Table S1. Patient’s characteristic of gene expression cohort. Table S2. Patient’s characteristic ex ...
BALR-6 locus encodes numerous alternative splice forms. Figure S2. Knockdown and overexpression of f...
Immunophenotypes of the leukemic cells remain stable for serial transplantations. (A) Representative...
Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...
List of antibodies used for the identification, characterization and isolation of bone marrow mesenc...
Figure S1. Flow cytometry analysis of CD45+CD33+ leukemia cells in peripheral blood of 14 and 7Â day...
Supplemental Information. Table S1. The source of primary antibodies used in this study. Table S2. T...
Table S1. Fluorochrome-coupled antibodies and/or chemical dyes for flow cytometry. Table S2. AML-der...
Figure S1. Showing generation and differentiation of hBMSC-TERT-Luc cell lines, Table S1 presenting ...
Figure S1. Expression of CD19/CD20, CD79A/B and RAG1/RAG2 in blood cancer cell lines. X axis: 164 bl...
Treatment resulted in a differential expression of 941 genes ( pâ <â0.05). (PDF 256 kb
Table S1-S2. Clinicopathological characteristics of CRC Patients named dataset (I) investigated by t...
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Table S1. Outcomes of patients with AITL who underwent allogeneic HCT. Table S2. Variables tested in...
Figure S5. Gating strategy for in vivo bone marrow samples. Bone marrows were harvested from KG1a-en...